Loading
companiesCompany
Forbion
A Dutch venture firm that funds European and North American biotech companies from formation to late-stage growth. Its homepage says it manages around EUR 5 billion across 11 funds.
Overview
Forbion describes itself as 'a global venture capital firm dedicated to advancing groundbreaking biotech innovations' and marks '20 years of impacting the future'. Its homepage states 'EUR 5bn across 11 funds', including a EUR 1.2 billion Forbion Growth Opportunities Fund III, a EUR 890 million Forbion Ventures VII and a EUR 200 million Forbion BioEconomy I. Strategies are split into Human Health (Formation, Ventures and Growth) and Planetary Health. The firm leads Series A and B rounds in therapeutics companies and, through its Growth funds, crossover rounds ahead of IPOs. Its portfolio and news pages are rendered client-side, so no oncology portfolio companies could be confirmed from a fetched page; the firm's oncology holdings should be checked before any are named.
Portfolio (2)
Filter the startups table| Company | Stage | Type | Cancers | Latest round |
|---|---|---|---|---|
| Mariana Oncology Watertown, MA, US | Acquired | radiopharma | Small-cell lung cancer | Acquisition 2024, $1B |
| Pheon Therapeutics London, GB | Startup | biotech | Series B 2024, $120M |
Notes
top- Portfolio and news pages load their content with JavaScript; no oncology company could be verified from fetched text. Naarden headquarters follows the task hint. Founding year not stated on fetched pages.
Similar pages
- CompanyAtlas Venture
Shares Mariana Oncology, Pheon Therapeutics and the tag vc.
- CompanyPerceptive Advisors
Shares Pheon Therapeutics and the tag vc.
- CompanyTCGX (TCG Crossover)
Shares Pheon Therapeutics and the tag vc.
- CompanyLightspeed Venture Partners
Shares Pheon Therapeutics and the tag vc.
- CompanyRA Capital Management
Shares Mariana Oncology and the tag vc.